BIOSIMILAR CARNIVAL 2018 - "CREATING COMMUNITY AWARENESS TOWARDS HEALTH AND WELLNESS IMPROVEMENT"

OFFICIATING SPEECH

 YAB DATO' SERI DR. WAN AZIZAH DR. WAN ISMAIL

 DEPUTY PRIME MINISTER OF MALAYSIA

 AND

MINISTER OF WOMEN, FAMILY AND COMMUNITY DEVELOPMENT

 

 BIOSIMILAR CARNIVAL 2018

 

“CREATING COMMUNITY AWARENESS TOWARDS HEALTH AND

 

WELLNESS IMPROVEMENT”

 

 

 

 

 

 

 

29 OCTOBER 2018 (MONDAY)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INNO BIO VENTURES SDN BHD

 

PUTRA NILAI, NEGERI SEMBILAN

Image removed.

 

 

1 | P a g e

 

Image removed.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2 | P a g e

 

SALUTATION

 

(Akan disediakan kemudian)

Image removed.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3 | P a g e

 

Image removed.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4 | P a g e

 

Dato’-Dato’, Tuan-tuan dan Puan-puan yang saya hormati sekalian.

 

 

1.                  Alhamdulillah,segala puji dan syukur kepada Allah S.W.T atas kurniaan kesempatan masa dan kesihatan untuk kita berkumpul pada hari ini.

 

2.                  Saya amat berbesar hati kerana telah dijemput untuk merasmikan program Karnival Biosimilar yang bertemakan, “Creating Community Awareness Towards Health and Wellness Improvement”.

 

3.                  Saya dimaklumkan terdapat tetamu-tetamu dari luar negara pada hari ini, maka izinkan saya untuk meneruskan ucapan dalam Bahasa Inggeris.

 

 

 

 

INTRODUCTION

 

 

Distinguished guests, ladies and gentlemen,

 

4.                  As you all know, biosimilars are medical products that are almost identical copies of an original product that is manufactured by a different company.

 

5.                  They are usually approved versions of original products that are manufactured when the original product’s patent expires.

 

6.                  The introduction of biosimilar products encourage competition in the market which can then lead to a reduction of about 30 to 40% in the cost of medicines.

 

7.                  This is particularly important in Malaysia, especially with an estimated 73% of total deaths in the country due to non-communicable diseases (NCDs), including cancer.

 

 

 

CANCER

 

 

Respected members of the audience,

Image removed.

 

 

 

 

5 | P a g e

 

8.                  I understand this Biosimilar Carnival is an initiative lead by Inno Bio Ventures Sdn Bhd (InnoBio), with the aim of supporting awareness of, and confidence in, the use of biosimilar products for healthcare professionals, physicians and patients.

 

9.                  I was informed that Inno Bio is currently focusing on the medicine and treatment of cancer, alongside other diseases.

 

10.           The government is fully aware and supportive of efforts made by organisations such as Inno Bio in organising campaigns and awareness programmes on life-threatening diseases such as cancer, within local communities.

 

11.           According to the statistics published by the National Cancer Registry Department, through the Malaysian National Cancer Registry Report 2007-2011, a total number of 103,407 new cancer cases were diagnosed in Malaysia during the period.

 

12.           According to statistics from Health Facts 2016, published by the Health Ministry, cancer is the third leading cause of deaths in government hospitals, contributing to 13.6% of deaths.

 

13.           This is very worrying, especially since the percentage of the number of deaths caused by cancer in 1996 in government hospitals was only 8.9%.

 

14.           The most common cancers in Malaysia among men (2007-2011) was colorectal cancer (16.4%), lung cancer (15.8%) and nasopharynx cancer” (8.1%).

 

15.           For women, the most common cancer was breast cancer (32.1%), colorectal cancer (10.7%) and cervical cancer (7.7%).

 

 

 

 

GOVERNMENT INITIATIVE - CANCER CONTROL PROGRAMME

 

 

Distinguished guests, ladies and gentlemen,

Image removed.

 

 

 

 

6 | P a g e

 

16.           Various steps have been taken by the government to combat, treat and reduce the instances of cancer as well as to improve the quality of life of cancer patients and their families under the National Strategic Plan for Cancer Control Programme, 2016-2020 (NSPCCP).

 

17.           Among the focus areas in the Cancer Control programme include health education and prevention; health screening and early detection; medicinal research; rehabilitation; and, palliative care.

 

18.           In July this year, I launched the Malaysian "War on Cancer" campaign which aims to increase awareness of the disease and to help patients receive fair and easy access to health support and care.

 

19.           The government is committed to engage in any efforts towards increasing the awareness of and knowledge about cancer among Malaysians, especially in helping one deal with it either as a patient, a family member, colleague or friend.

 

 

 

KPWKM’s INVOLVEMENT IN PUBLIC HEALTH AWARENESS

 

 

Ladies and gentlemen,

 

 

20.           Health treatment can be a tremendous burden on patients and families involved, especially for households with limited incomes.

 

21.           Based on the Asean Costs in Oncology study by the Sydney-based George Institute for Global Health, approximately 51% of cancer patients in Malaysia will be pushed into economic hardship a year after being diagnosed.

 

22.           This situation is even worse if the cancer is diagnosed in its later stages, which requires costlier treatments.

 

23.           This is why the focus must be on preventive measures and early detection of cancer.

 

24.                  The Ministry of Women, Family and Community Development, through the National Population and Family Development Board (LPPKN),

Image removed.

 

7 | P a g e

 

provides aid for screening tests of breast cancer and cervical cancer through subsidised mammogram screenings and pap smears, as well as subsidised HPV Vaccinations.

 

25.                  From May 2007 to August 2018, nearly 400,000 women have registered for subsidised mammogram screenings and a total of 348,386 have undergone mammogram tests.

 

26.                  From January to September this year, 16,053 women have received their vaccinations under the HPV Vaccination Programme.

 

 

BIOSIMILAR INITIATIVE – FROM GOVERNMENT PERSPECTIVE

 

 

Respected members of the audience,

 

 

27.           As mentioned earlier by the Chairman of Inno Bio, Tan Sri Abdul Rahman Mamat, Biosimilar Initiatives is a promising strategy that can benefit people and our country.

 

28.           Enabling locally-manufactured biosimilar products will offer affordable cost-effective medicines and help in the treatment of diseases such as cancers.

 

29.           The government identified these needs and for that reason, Inno Bio was established by the government in 2002 with the infrastructure and expertise to locally produce biologic medicines for the domestic and global market.

 

30.           With the efforts and synergistic collaboration among related parties, I am confident that our aspiration for Malaysia to improve its accessibility and quality of healthcare can be achieved.

 

31.           Additionally, advances in biotechnology are also seen as a means of providing employment opportunities to Malaysians and to indirectly produce more skilled workers in Malaysia.

Image removed.

 

 

 

 

 

 

 

 

8 | P a g e

 

COLLABORATION BETWEEN INNO BIO AND D8 ORGANIZATION FOR ECONOMIC COOPERATION

 

Ladies and gentlemen,

 

 

32.           I am happy to share that Inno Bio has received international recognition in 2016 from the D8 Organization for Economic Cooperation, also known as Developing-8, through biosimilar product invention efforts in collaboration with Aryogen Pharmed.

 

33.           The D-8 Organization is an organisation for development co-operation among Bangladesh, Egypt, Indonesia, Iran, Malaysia, Nigeria, Pakistan and Turkey.

 

34.           This is an excellent example of technology transfer strategies, and demonstrates that biosimilar initiatives are relevant and accepted globally.

 

35.           This cooperation will fulfil technology market functions; information dissemination on technological capabilities, achievements, and needs among the D-8 Member Countries.

 

36.           This also proves that our country is capable of producing our own high impact biopharmaceutical products through strategic partnerships.

 

37.           Today, we will witness the MoU exchange between Inno Bio and D-8.

 

 

38.           This aims to strengthen the engagement between Inno Bio and D-8, in order to increase inter-related cooperation between Islamic states, in the areas of innovation and technology transfers, and business opportunities and support.

 

39.           With this platform, I look forward to more collaboration between industry players in exchanging expertise, technologies, and business opportunities.

Image removed.

 

 

 

 

 

 

 

 

9 | P a g e

 

CLOSING

 

 

Ladies and gentlemen,

 

 

40.           It is my hope that efforts such as this will continue in order for us to create awareness among the public in creating a more healthy and prosperous society.

 

41.           On that note, and with the recitation of “Bismillahir Rahmanir Rahim”, it is my pleasure to launch the Biosimilar Carnival 2018.

 

Thank you.

Image removed.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10 | P a g e

 

Tarikh
Tempat
INNO BIO VENTURES SDN BHD PUTRA NILAI, NEGERI SEMBILAN